CORBUS PHARMACEUTICALS HOLDI (CRBP) Institutional Shareholders
CORBUS PHARMACEUTICALS HOLDI (CRBP) is currently reported in institutional portfolios tracked by InsiderSet based on the latest available SEC Form 13F filings for the quarter ended June 30, 2026. The institutional investors covered on this page collectively reported approximately $129.09M in CRBP holdings during the latest filing period.
Cormorant Asset Management, Lp is currently the largest disclosed institutional shareholder of CRBP tracked by InsiderSet, reporting ownership valued at approximately $22.00M in its June 30, 2026 SEC Form 13F filing. Based on current market prices and the latest disclosed share count, the position is now estimated to be worth approximately $17.54M, representing an estimated loss of -20.26% since the filing period.
The top 10 institutional shareholders tracked on this page collectively account for approximately 73% of the total disclosed CRBP value among the investors covered in this analysis. Major shareholders include Cormorant Asset Management, Lp, Orbimed Advisors Llc, Blackrock, Inc., and several other long-term asset managers with concentrated positions in CORBUS PHARMACEUTICALS HOLDI (CRBP).
This page ranks the largest institutional CRBP shareholders using publicly disclosed SEC Form 13F data, including reported values, estimated current holding values, portfolio allocation percentages, ownership concentration metrics, and historical holding changes across major hedge funds and investment firms.
Institutional Holders
106
Total Reported Value
$129.09M
Largest Holder
Cormorant Asset Management, Lp
Largest Position
$22.00M
Insider Transactions (90d)
5
Latest Filing Quarter
Q2 2026
New Institutional Positions
143
Funds Exiting Positions
0
| Name | Investor/Manager | Portfolio % | Quantity | Reported Balance | Current Estimated Value | Gain/loss Since Filing | Estimated Portfolio Performance |
|---|---|---|---|---|---|---|---|
| Cormorant Asset Management, Lp | 1.13% | 2,344,971 | $21,995,828 | $17,540,383 | -$4,455,445 | -20.26% | |
| Orbimed Advisors Llc | 0.31% | 1,737,287 | $16,295,752 | $12,994,907 | -$3,300,845 | -20.26% | |
| Blackrock, Inc. | 0.00% | 1,331,135 | $12,486,047 | $9,956,890 | -$2,529,157 | -20.26% | |
| Aberdeen Group Plc | 0.02% | 1,321,750 | $12,398,015 | $9,886,690 | -$2,511,325 | -20.26% | |
| Vanguard Capital Management Llc | 0.00% | 760,940 | $7,137,617 | $5,691,831 | -$1,445,786 | -20.26% | |
| Jones Hill Capital Lp | 1.30% | 653,572 | $6,130,505 | $4,888,719 | -$1,241,786 | -20.26% | |
| Prosight Management, Lp | 1.05% | 650,000 | $6,097,000 | $4,862,000 | -$1,235,000 | -20.26% | |
| Stonepine Capital Management, Llc | 3.03% | 425,000 | $3,986,500 | $3,179,000 | -$807,500 | -20.26% | |
| Geode Capital Management, Llc | 0.00% | 423,374 | $3,972,122 | $3,166,838 | -$805,284 | -20.27% | |
| Adar1 Capital Management, Llc | 0.19% | 421,787 | $3,956,362 | $3,154,967 | -$801,395 | -20.26% | |
| Diadema Partners Lp | 1.00% | 301,264 | $2,825,856 | $2,253,455 | -$572,401 | -20.26% | |
| Susquehanna International Group, Llp | 0.00% | 293,203 | $2,750,244 | $2,193,158 | -$557,086 | -20.26% | |
| State Street Corp | 0.00% | 254,672 | $2,388,823 | $1,904,947 | -$483,876 | -20.26% | |
| Dimensional Fund Advisors Lp | 0.00% | 190,214 | $1,783,533 | $1,422,801 | -$360,732 | -20.23% | |
| Exome Asset Management Llc | 1.07% | 184,914 | $1,734,493 | $1,383,157 | -$351,336 | -20.26% | |
| Mirae Asset Global Etfs Holdings Ltd. | 0.00% | 151,640 | $1,422,383 | $1,134,267 | -$288,116 | -20.26% | |
| Jane Street Group, Llc | 0.00% | 139,133 | $1,305,068 | $1,040,715 | -$264,353 | -20.26% | |
| Northern Trust Corp | 0.00% | 124,906 | $1,171,618 | $934,297 | -$237,321 | -20.26% | |
| Vanguard Fiduciary Trust Co | 0.00% | 112,397 | $1,054,284 | $840,730 | -$213,554 | -20.26% | |
| Vanguard Portfolio Management Llc | 0.00% | 111,302 | $1,044,013 | $832,539 | -$211,474 | -20.26% | |
| Renaissance Technologies LLC | Jim Simons | 0.00% | 110,822 | $1,039,510 | $828,949 | -$210,561 | -20.26% |
| Dafna Capital Management Llc | 0.19% | 107,773 | $1,010,911 | $806,142 | -$204,769 | -20.26% | |
| Citadel Advisors Llc | 0.00% | 92,154 | $864,405 | $689,312 | -$175,093 | -20.26% | |
| Advisory Services Network, Llc | 0.01% | 89,951 | $843,740 | $672,833 | -$170,907 | -20.26% | |
| Marshall Wace, Llp | 0.00% | 79,331 | $744,125 | $593,396 | -$150,729 | -20.26% | |
| Bnp Paribas Financial Markets | 0.00% | 78,120 | $732,766 | $584,338 | -$148,428 | -20.26% | |
| Persistent Asset Partners Ltd | 0.23% | 76,919 | $721,500 | $575,354 | -$146,146 | -20.26% | |
| Susquehanna Portfolio Strategies, Llc | 0.01% | 75,979 | $712,683 | $568,323 | -$144,360 | -20.26% | |
| Xtx Topco Ltd | 0.01% | 67,654 | $634,595 | $506,052 | -$128,543 | -20.26% | |
| Verdad Advisers, Lp | 0.57% | 63,603 | $596,596 | $475,750 | -$120,846 | -20.26% | |
| Goldman Sachs Group Inc | 0.00% | 62,863 | $589,655 | $470,215 | -$119,440 | -20.26% | |
| Charles Schwab Investment Management Inc | 0.00% | 55,455 | $520,168 | $414,803 | -$105,365 | -20.26% | |
| Hsbc Holdings Plc | 0.00% | 55,224 | $504,747 | $413,076 | -$91,671 | -18.16% | |
| Ubs Group Ag | 0.00% | 48,797 | $457,716 | $365,002 | -$92,714 | -20.26% | |
| Bank Of New York Mellon Corp | 0.00% | 45,282 | $424,746 | $338,709 | -$86,037 | -20.26% | |
| Rangeley Capital, Llc | 0.38% | 44,000 | $412,720 | $329,120 | -$83,600 | -20.26% | |
| Cantor Fitzgerald, L. P. | 0.01% | 40,098 | $376,117 | $299,933 | -$76,184 | -20.26% | |
| Driehaus Capital Management Llc | 0.00% | 38,977 | $365,604 | $291,548 | -$74,056 | -20.26% | |
| Acadian Asset Management Llc | 0.00% | 37,389 | $349,000 | $279,670 | -$69,330 | -19.87% | |
| Lmr Partners Llp | 0.00% | 35,500 | $332,990 | $265,540 | -$67,450 | -20.26% | |
| Engineers Gate Manager Lp | 0.00% | 29,800 | $279,524 | $222,904 | -$56,620 | -20.26% | |
| Caption Management, Llc | 0.01% | 27,852 | $261,252 | $208,333 | -$52,919 | -20.26% | |
| Price T Rowe Associates Inc | 0.00% | 26,271 | $247,000 | $196,507 | -$50,493 | -20.44% | |
| Velan Capital Investment Management Lp | 0.15% | 26,000 | $243,880 | $194,480 | -$49,400 | -20.26% | |
| Jump Financial, Llc | 0.00% | 25,800 | $242,004 | $192,984 | -$49,020 | -20.26% | |
| Pale Fire Capital Se | 0.02% | 24,301 | $227,943 | $181,771 | -$46,172 | -20.26% | |
| Y-Intercept (Hong Kong) Ltd | 0.00% | 22,646 | $212,419 | $169,392 | -$43,027 | -20.26% | |
| American Century Companies Inc | 0.00% | 22,507 | $211,116 | $168,352 | -$42,764 | -20.26% | |
| Brevan Howard Capital Management Lp | 0.00% | 22,477 | $210,834 | $168,128 | -$42,706 | -20.26% | |
| Nuveen, Llc | 0.00% | 22,308 | $209,249 | $166,864 | -$42,385 | -20.26% |
Frequently asked questions about CRBP
Who owns the most CRBP stock?
The largest holders of CRBP are typically major institutional investors such as asset managers and hedge funds reporting on Form 13F. The table above ranks tracked superinvestors by reported position size using the latest available filings for CORBUS PHARMACEUTICALS HOLDI (CRBP).
Is CRBP widely held by superinvestors?
Many widely followed stocks like CRBP appear across numerous superinvestor portfolios because of liquidity, index inclusion, and fundamentals. The holder count and table above show how broadly CRBP is represented among the institutional managers we track.
What do “Current Estimated Value”, “Gain/loss Since Filing”, and “Estimated Portfolio Performance” mean?
Current Estimated Value is reported share quantity from the latest 13F times our most recent split-adjusted U.S. session close. Gain/loss Since Filing is that estimate minus the reported 13F dollar value; Estimated Portfolio Performance is that difference as a percent of the reported value. Green means the estimate is above the filing value; red means below (not purchase cost). If many filers share the same implied filing price per share, the performance % may match across rows. These are not official fund marks or live quotes.